Loading interface...

Ricovir-EM Tablet

Manufactured byMYLAN
ContainsTenofovir (300 mg) + Emtricitabine (200 mg)
Description
Ricovir-EM Tablet is a combination medicine used for the treatment of treat human immunodeficiency virus (HIV) infections. This medicine is not a cure for HIV; it only prevents the virus from multiplying in your body. Monitoring of liver function and kidney function may be necessary while receiving this medicine based on the clinical condition. This medicine is not recommended for use in patients less than 12 years of age.

Side effects

Major & minor side effects for Ricovir-EM Tablet

  • Chest pain
  • Cough or hoarseness
  • Fever or chills
  • Painful or burning urination
  • Pale skin
  • Diarrhea
  • Dizziness
  • Headache
  • Abdominal pain
  • Nausea and vomiting
  • Indigestion
  • Depression
  • Joint pain
  • Weight loss
  • Rash
  • Itching
  • Passing gas

Uses of Ricovir-EM Tablet

What is it prescribed for?

  • HIV infection
  • Pre-exposure prophylaxis
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time required for this medicine to show its effect is not clinically established.
  • How long do the effects of this medicine last?
    The time until which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to tenofovir, emtricitabine, or any other inactive ingredients present along with these medicines.

Severe renal impairment

This medicine is not recommended for use in patients with severe renal impairment (creatinine clearance less than 30 ml/min) due to the increased risk of serious adverse effects.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.
General warnings

Immune reconstitution syndrome

This medicine should be used with caution due to the increased risk of Immune reconstitution syndrome. Report any unusual symptoms to the doctor immediately. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Fat redistribution

This medicine may cause fat gain or fat loss from the body. This may result in peripheral wasting, facial wasting, breast enlargement, and Cushingoid appearance. Close monitoring of body weight and body fat distribution is necessary while receiving this medicine. Any changes in the body should be informed to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Lactic acidosis

This medicine should be used with caution due to the increased risk of Lactic acidosis. Report any unusual symptoms to the doctor immediately. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Opportunistic infections

The patients receiving this medicine may develop opportunistic infections such as pneumonia, herpes virus infections, etc. Report any unusual symptoms to the doctor immediately. Appropriate patient/caregiver education, corrective measures, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Hemodialysis

This medicine is not recommended for use in patients requiring hemodialysis. Replacement with a suitable alternative should be considered based on the clinical condition.

Dizziness and Drowsiness

This medicine may cause dizziness or drowsiness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Hepatotoxicity

This medicine should be used with caution in patients with a history of liver diseases and active liver diseases due to the increased risk of worsening of the patient's condition. Hepatotoxicity has been reported in rare cases during treatment with this medicine. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Decreased bone mineral density

This medicine should be used with caution due to the increased risk of decreased bone mineral density. Report any unusual symptoms to the doctor immediately. Close monitoring of bone mineral density, appropriate corrective measures, or dose adjustments may be required in some cases based on the clinical condition of the patient.

Missed Dose

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Cisplatin

Gentamicin

Leflunomide

Aspirin

Tobramycin

Efavirenz

Lamivudine

Methotrexate

Disease interactions

Renal Dysfunction

This medicine should be used with extreme caution in patients with renal diseases due to the increased risk of serious adverse effects. Renal function should be assessed before initiating treatment with this medicine. Close monitoring of renal function, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Hepatic impairment

This medicine should be used with extreme caution in patients with liver diseases due to the increased risk of worsening of the patient's condition. Close monitoring of liver function is recommended during treatment with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine exactly as instructed by the doctor. Do not take in larger or smaller quantities than recommended. Ensure that proper hygiene measures are adopted. Complete the course of treatment to prevent the spread of the infection. Close monitoring of liver function and kidney function may be necessary while receiving this medicine based on the clinical condition.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine works by stopping the human immunodeficiency virus (HIV) from multiplying. This helps in reducing the chances of development of acquired immunodeficiency syndrome (AIDS) and other HIV-related illnesses.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Antiviral combinations

Schedule

Schedule H

Truvada Dosage, Side Effects [Internet]. AIDSinfo. 2018 [cited 23 April 2018]. Available from:

https://aidsinfo.nih.gov/drugs/406/truvada/0/patient

[Internet]. Gilead.com. 2018 [cited 23 April 2018]. Available from:

https://www.gilead.com/~/media/files/pdfs/medicines/hiv/truvada/truvada_pi.pdf

DailyMed - Emtricitabine and tenofovir disoproxil fumarate tablet, film coated [Internet]. Dailymed.nlm.nih.gov. 2018 [cited 23 April 2018]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d0b3d18b-7e5d-49ea-bcaf-8408414e8094

Emtricitabine and Tenofovir: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2018 [cited 23 April 2018]. Available from:

https://medlineplus.gov/druginfo/meds/a612036.html
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 11 Jul 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.